Plum 360 vs Plum Solo: Which ICU Medical Infusion Pump Fits Your Facility?

After managing procurement for a mid-sized hospital network for a few years, I've developed a pretty deep appreciation for how small equipment decisions play out across an entire facility. When our team was evaluating the new fleet of infusion pumps, the choice came down to two workhorses from the same manufacturer: the ICU Medical Plum 360 and the Plum Solo.

This isn't a case of 'good vs bad.' Both pumps are solid. But they're designed for fundamentally different use cases and budgets. Let me walk you through the dimensions that mattered most to us—and that I think will matter to you.

The Core Framework: Why Compare These Two?

If you're reading this, you're probably not starting from scratch. You're likely looking at either a) upgrading an existing fleet, or b) adding capacity to handle specific patient volumes. The Plum 360 is the 'everything' pump—smart, multi-channel, and heavy on data integration. The Plum Solo is the more straightforward, reliable, and cost-effective option.

The mistake I see procurement teams make is picking the 'more advanced' pump for every scenario, assuming it's always better. It's not. You need to match the tool to the task.

Comparison Dimensions We Used

• Total Cost of Ownership (TCO) over 5 years
• Workflow Impact — training, setup time, maintenance
• Clinical Flexibility — drug library, tubing sets
• ROI Justification — how each pump affects your capital budget

Dimension 1: Total Cost of Ownership (TCO)

This is where the biggest surprise hit us. When we first saw the sticker price, the Plum 360 was roughly 1.8x to 2.2x the cost of the Plum Solo per unit, as of our Q3 2024 evaluation. On paper, that's a no-brainer for budget-conscious administrators.

But—and this is the part I got wrong initially—the TCO flips depending on your volume and usage patterns. The Plum Solo uses a specific, proprietary tubing set that's about $0.60 to $0.80 more per set than the Plum 360's standard IV set. If you run 100,000 infusions per month across 50 pumps, that adds up to ~$72,000 annually in disposables.

Wait, let me rephrase that. Actually, it's more nuanced. The Plum 360 uses a 'smart' set that's cheaper per unit, but it requires specific inventory management. The Plum Solo set is simpler but pricier. So:

• Low volume (under 2,000 infusions/pump/year): Plum Solo wins on TCO. The acquisition cost difference outweighs the disposables surcharge.
• High volume (over 5,000 infusions/pump/year): Plum 360 starts to pull ahead. The disposables savings become significant.

I should add: our finance team really grumbled about this until I showed them the full-year projection. The disposables cost is a line item nobody thinks about until it's too late.

Dimension 2: Workflow Impact

This one is trickier to quantify, but it's the dimension that caused us a few headaches. I'll be direct: the Plum Solo is much easier to train staff on. A new nurse can be up and running in about 15 minutes with the basic functions. The Plum 360, with its larger display, multiple channels, and the 'Plum IQ' dose-error reduction software, requires a full training module—call it 45 minutes to an hour per person.

If you're a 200-bed hospital with a 30% annual nursing turnover, that's roughly 60 training hours per year just for pump orientation. At an average nurse's hourly rate of, say, $45/hour, that's $2,700 annually in lost productive time. Scale that up for larger facilities and it's meaningful.

The Plum 360 also generates more data. It connects to the hospital's EMR system, logging every infusion event. This is amazing for quality control and for the CNO's reporting dashboard. But it also means your IT team needs to manage integration and your clinical engineering team needs to handle software updates. The Plum Solo? Plug it in, run the line, hit 'start.'

The surprise for me: I assumed the more complex pump would save nursing time overall. It doesn't, at least not on the floor. The time savings from data integration show up in retrospective reporting, not in daily workflow. If your facility's priority is efficient patient throughput, the Solo is faster. If you're obsessed with data-driven quality improvement, the 360 is better.

Dimension 3: Clinical Flexibility

This is where the Plum 360 clearly outshines its sibling. The Plum 360 can handle:

• Dual-channel simultaneous infusions (two different drugs at different rates)
• Large drug library with built-in Dose Error Reduction System (DERS)
• Integration with the ICU Medical PlumWatch centralized monitoring system

The Plum Solo is fundamentally a single-channel pump. You can cycle it through different patients, but you can't run two concurrent infusions. This makes the Solo perfect for standard maintenance IVs, but not for critical care or complex multi-drug regimens.

In our facility, we ended up using them side by side: Plum 360s in the ICU and step-down units; Plum Solos on the general medical-surgical floors and outpatient infusion centers. The Plums 360 accounted for about 35% of our fleet but handled 60% of the 'high-risk' infusion volume.

If you ask me, this is the most critical decision criteria: where will the pumps be used? If the answer is 'everywhere, general purpose,' go with the 360. If you're equipping a high-volume, low-complexity unit, the Solo is the better fit.

I only believed this after ignoring it. We initially bought 90% Plum 360s because we wanted 'the best.' Three months in, our med-surg nurses were complaining about the complexity, and the disposables budget was killing us. We swapped half the fleet out for Solos within six months.

Dimension 4: ROI Justification for Administration

This is the dimension that gets overlooked in clinical comparisons. How do you pitch this to the CFO or the capital committee?

The Plum 360 has a higher upfront cost and longer payback period—typically 3-4 years if you factor in the disposables savings and quality improvements (fewer adverse drug events). The Plum Solo has a shorter payback (2-2.5 years) if you're looking at pure capital efficiency.

But here's the kicker: the Plum Solo's disposables cost is a variable operational expense that hits your annual budget, not a capital expense. Administrators often prefer to have the cost in the capex bucket (the 360) rather than in the opex bucket (the Solo's expensive disposables) because capex limits are more flexible in large organizations.

I know, that sounds backwards. But I've seen finance directors approve a $500,000 fleet upgrade because it was 'capital' while rejecting a $35,000 annual increase in disposables because it was 'operating.' The logic is flawed, but it's real.

Final Decision: What We Did

After running the numbers, we settled on a 60/40 split in favor of the Plum Solo. The 40% of Plum 360s went to ICU, Step-down, and NICU. The 60% Plum Solos covered general floors, ED rapid infusions, and outpatient infusion.

Our total five-year cost projection (including disposables, training, and maintenance) for this mixed fleet was ~$1.2 million. Had we gone 100% Plum 360, it would have been ~$1.5 million. Had we gone 100% Plum Solo, it would have been ~$1.1 million, but we would have lacked clinical flexibility for high-acuity areas.

The time certainty premium we paid for the 360 in critical areas was worth it. In March 2024, we had a code situation where the dual-channel capability of a Plum 360 was essential. The alternative—maintaining two separate pumps—would have delayed setup by 3-4 minutes in a situation where every second mattered. The extra $2,700 per 360 vs a Solo was a small price for that certainty.

Bottom line for procurement:

• Pick the Plum Solo if: You're on a tight budget, equipping low-acuity areas, or dealing with high turnover that demands minimal training.
• Pick the Plum 360 if: You have high infusion volumes, need data integration, or are equipping critical care units.

And whatever you do, don't just pick one pump for the whole hospital. The value is in the mix.